<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Muscle-eye-<z:e sem="disease" ids="C0006111" disease_type="Disease or Syndrome" abbrv="">brain disease</z:e> (MEB) is an <z:hpo ids='HP_0000007'>autosomal recessive</z:hpo> disorder characterized by <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo>, ocular abnormalities, and <z:hpo ids='HP_0001339'>lissencephaly</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Mammalian O-mannosyl glycosylation is a rare type of protein modification that is observed in a limited number of <z:chebi fb="0" ids="17089">glycoproteins</z:chebi> of brain, nerve, and skeletal muscle </plain></SENT>
<SENT sid="2" pm="."><plain>Here we isolated a human cDNA for protein O-<z:chebi fb="0" ids="37684">mannose</z:chebi> beta-1,2-N-acetylglucosaminyltransferase (POMGnT1), which participates in O-mannosyl glycan synthesis </plain></SENT>
<SENT sid="3" pm="."><plain>We also identified six independent mutations of the POMGnT1 gene in six patients with MEB </plain></SENT>
<SENT sid="4" pm="."><plain>Expression of most frequent mutation revealed a great loss of the enzymatic activity </plain></SENT>
<SENT sid="5" pm="."><plain>These findings suggest that interference in O-mannosyl glycosylation is a new pathomechanism for <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo> as well as <z:hpo ids='HP_0002269'>neuronal migration disorder</z:hpo> </plain></SENT>
</text></document>